Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 106Neoplasm Metastasis 9Ovarian Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Neoplasms, Male 3Prostatic Neoplasms 2Obesity 2Carcinoma, Non-Small-Cell Lung 2Breast Diseases 2Breast Carcinoma In Situ 2Breast Cancer Metastatic 2Arthralgia 2Triple Negative Breast Neoplasms 1Sexuality 1Sexual Dysfunctions, Psychological 1Recurrence 1Primary Breast Cancer ER+ve 1Premenopausal Breast Cancer 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Multiple Endocrine Neoplasia Type 1 1Metastatic Beast Cancer 1Locoregional Recurrence 1Hyperglycemia 1Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Hormone Receptor Positive Malignant Neoplasm of Breast 1HR Positive HER2 Negative Advanced Breast Cancer 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × exemestane × Clear all
NCT06630325 2026-04-28

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
6 enrolled 3 charts
GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00031889 2012-05-15

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Swiss Cancer Institute

Phase 2 Completed
5 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡